Yildiz, İ. Et Al. 2011. Response rates and adverse effects of continuous once-daily sunitinib in patients with advanced renal cell carcinoma: a single-center study in Turkey.. Japanese journal of clinical oncology , vol.41, no.12 , 1380-7.

Yildiz, İ., Sen, F., Basaran, M., Ekenel, M., Agaoglu, F., Darendeliler, E., ... Tunc, H. M.(2011). Response rates and adverse effects of continuous once-daily sunitinib in patients with advanced renal cell carcinoma: a single-center study in Turkey.. Japanese journal of clinical oncology , vol.41, no.12, 1380-7.

Yildiz, İBRAHİM Et Al. "Response rates and adverse effects of continuous once-daily sunitinib in patients with advanced renal cell carcinoma: a single-center study in Turkey.," Japanese journal of clinical oncology , vol.41, no.12, 1380-7, 2011

Yildiz, İBRAHİM Et Al. "Response rates and adverse effects of continuous once-daily sunitinib in patients with advanced renal cell carcinoma: a single-center study in Turkey.." Japanese journal of clinical oncology , vol.41, no.12, pp.1380-7, 2011

Yildiz, İ. Et Al. (2011) . "Response rates and adverse effects of continuous once-daily sunitinib in patients with advanced renal cell carcinoma: a single-center study in Turkey.." Japanese journal of clinical oncology , vol.41, no.12, pp.1380-7.

@article{article, author={İBRAHİM YILDIZ Et Al. }, title={Response rates and adverse effects of continuous once-daily sunitinib in patients with advanced renal cell carcinoma: a single-center study in Turkey.}, journal={Japanese journal of clinical oncology}, year=2011, pages={1380-7} }